Gene · 1760
Papers3,275
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 3,275
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Multiparametric bone MRI targeting aides lesion selection for CT-guided sclerotic bone biopsies in metastatic castrate resistant prostate cancer. | Cancer Imaging | 2023 | 38102655 | PubTator, text mining | PubMed |
| Discovery of pyrazolopyrimidines that selectively inhibit CSF-1R kinase by iterative design, synthesis and screening against glioblastoma cells. | RSC Med Chem | 2023 | 38099057 | PubTator, text mining | PubMed |
| Transcriptomic meta-analysis reveals ERRα-mediated oxidative phosphorylation is downregulated in Fuchs' endothelial corneal dystrophy. | PLoS One | 2023 | 38096202 | PubTator, text mining | PubMed |
| A self calibrating, magnetic sensor approach accurately positions an aortic damage control stent in a porcine model. | Trauma Surg Acute Care Open | 2023 | 38089400 | PubTator, text mining | PubMed |
| No increase in the CTG repeat size during transmission from parent with expanded allele: false suspicion of contraction phenomenon. | Adv Lab Med | 2023 | 38075944 | PubTator, text mining | PubMed |
| Design and development of a digital intervention for workplace stress and mental health (EMPOWER). | Internet Interv | 2023 | 38054076 | PubTator, text mining | PubMed |
| Acute cricopharyngeal achalasia after general anesthesia in myotonic dystrophy: A case report. | Medicine (Baltimore) | 2023 | 38050269 | PubTator, text mining | PubMed |
| Editorial: Personalized medicine for neuromuscular disorders. | Front Cell Dev Biol | 2023 | 38033860 | PubTator, text mining | PubMed |
| Targeting the Expanded TCF4/Fuchs' Endothelial Corneal Dystrophy CUG Repeat with Morpholino Peptide Conjugates. | ACS Omega | 2023 | 38024683 | PubTator, text mining | PubMed |
| Advances in oncolytic herpes simplex virus and adenovirus therapy for recurrent glioma. | Front Immunol | 2023 | 38022620 | PubTator, text mining | PubMed |
| Myotonic Dystrophy-1 and Parkinson's Disease: Clarify the Role of CTG-repeat Size and Variants in VPS13C, SYNJ1, and DNAJC6. | Ann Indian Acad Neurol | 2023 | 38022484 | PubTator, text mining | PubMed |
| Double Trouble Myotonic Dystrophy Type-1 and Parkinson Syndrome Associated with Variants in SYNJI, VPS13C, and DNAJC6. | Ann Indian Acad Neurol | 2023 | 38022443 | PubTator, text mining | PubMed |
| Assessment of the viability of integrating virtual reality programs in practical tests for the Korean Radiological Technologists Licensing Examination: a survey study | J Educ Eval Health Prof | 2023 | 38013201 | PubTator, text mining | PubMed |
| Implementation of a high sensitivity cardiac troponin I assay and risk of myocardial infarction or death at five years: observational analysis of a stepped wedge, cluster randomised controlled trial. | BMJ | 2023 | 38011922 | PubTator, text mining | PubMed |
| Atmospheric Turbulence Aberration Correction Based on Deep Learning Wavefront Sensing. | Sensors (Basel) | 2023 | 38005546 | PubTator, text mining | PubMed |
| Loss of p53 function promotes DNA damage-induced formation of nuclear actin filaments. | Cell Death Dis | 2023 | 38001089 | PubTator, text mining | PubMed |
| The Dysfunction of Ca2+ Channels in Hereditary and Chronic Human Heart Diseases and Experimental Animal Models. | Int J Mol Sci | 2023 | 37958665 | PubTator, text mining | PubMed |
| Mediating oxidative stress through the Palbociclib/miR-141-3p/STAT4 axis in osteoporosis: a bioinformatics and experimental validation study. | Sci Rep | 2023 | 37949959 | PubTator, text mining | PubMed |
| Prognostic Utility of Cardiovascular Magnetic Resonance-Based Phenotyping in Patients With Muscular Dystrophy. | J Am Heart Assoc | 2023 | 37929714 | PubTator, text mining | PubMed |
| Advances in the discovery and analyses of human tandem repeats. | Emerg Top Life Sci | 2023 | 37905568 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1760/papers?page=11